| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is epi? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is dopamine? |  | Definition 
 
        | dopamine receptor, B agonist |  | 
        |  | 
        
        | Term 
 
        | what kind of drug is tyramine? |  | Definition 
 
        | indirectly acting sympathomimetic |  | 
        |  | 
        
        | Term 
 
        | what kind of drug is ephedrine? |  | Definition 
 
        | directly and indirectly acting sympathomimetic |  | 
        |  | 
        
        | Term 
 
        | what kind of drug is amphetamine? |  | Definition 
 
        | indirectly acting sympathomimetic |  | 
        |  | 
        
        | Term 
 
        | what kind of drug is phenylephrine? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is clonidine? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is isoproterenol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is dobutamine? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is metaproterenol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is albuterol? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what kind of drug is terbutaline? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what drug is used when have a stuffy nose to clear airway? |  | Definition 
 
        | phenylephrine (a1 agonist) |  | 
        |  | 
        
        | Term 
 
        | what is a drug that can be used in the ICU to increase peripheral resistance without increasing CO? |  | Definition 
 
        | phenylephrine (a1 agonist) |  | 
        |  | 
        
        | Term 
 
        | prototype drug for a2 receptor |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | at the neuroeffector junction - on the nerve terminus itself feeds back and binds a2 receptor of the neuron releasing NE and inhibits release of more NE
 feedback regulator of NE release
 |  | 
        |  | 
        
        | Term 
 
        | prototype drug for B1 receptor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | prototype drug for B2 receptor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the 3 ways adrenergic agonists can have an effect? |  | Definition 
 
        | 1. act directly on adrenergic receptors 2. act by promoting release of endogenous NE
 3. mixed actions
 |  | 
        |  | 
        
        | Term 
 
        | actions of a1 receptor agonists |  | Definition 
 
        | 1. vasoconstriction - increases peripheral resistance and BP 2. venoconstriction - decreases capacitance and increases venous pressure and right heart filling pressure
 3. contraction of the iris radial (dilator) muscle - induces myddriasis
 4. constriction of bladder and intestine sphincters
 |  | 
        |  | 
        
        | Term 
 
        | arteriole effect of a1 receptor agonists |  | Definition 
 
        | vasocontriction increases peripheral resistance and BP
 |  | 
        |  | 
        
        | Term 
 
        | venous effect of a1 receptor agonists |  | Definition 
 
        | venoconstriction decreases capacitance
 increases venous pressure and right heart filling pressure
 |  | 
        |  | 
        
        | Term 
 
        | effect of a1 receptor agonists in the eye |  | Definition 
 
        | contraction of the iris radial (dilator) muscle induces mydriasis
 |  | 
        |  | 
        
        | Term 
 
        | effect of a1 receptor agonists on bladder and intestine |  | Definition 
 
        | contraction of sphincters |  | 
        |  | 
        
        | Term 
 
        | actions of a2 receptor agonists |  | Definition 
 
        | inhibition of neuronal NE release - decrease BP |  | 
        |  | 
        
        | Term 
 
        | prototype a2 receptor agonist |  | Definition 
 
        | clonidine developed to be an anti-HTN drug - decrease BP by inhibiting neuronal release of NE
 |  | 
        |  | 
        
        | Term 
 
        | prototype a1 receptor agonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effect of phenylephrine infusion? |  | Definition 
 
        | BP increase BV are related to heart via baroreceptors
 constrict vessels --> decrease CO --> decrease HR and SV via baroreceptors
 reversible
 |  | 
        |  | 
        
        | Term 
 
        | normal response to getting up from laying down (getting up in the morning)? |  | Definition 
 
        | BP drops initially - a1 receptors cause constriction to stop from crashing need more blood - HR and contractility increase - vasoconstrict
 |  | 
        |  | 
        
        | Term 
 
        | side effects of a1 blockage |  | Definition 
 
        | orthostatic HTN and syncope - block normal phys that allows for vasoconstriction problem elderly woman on a1 receptor blocker for HTN - can fall and break a hip
 |  | 
        |  | 
        
        | Term 
 
        | a1 receptor mediates ____ in BV |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | don't constrict - stiffen and decrease compliance causes - blood to be increased back to the heart and increase right heart filling pressure and thus pre-load
 |  | 
        |  | 
        
        | Term 
 
        | actions of B1 receptor agonists |  | Definition 
 
        | 1. increased cardiac contractility and HR 2. increased lipolysis
 3. production of renin from the kidneys
 |  | 
        |  | 
        
        | Term 
 
        | effects of B1 receptor agonist on heart |  | Definition 
 
        | increased contractility and HR |  | 
        |  | 
        
        | Term 
 
        | effects of B1 receptor agonist on peripheral fat |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effects of B1 receptor agonist on renin production |  | Definition 
 
        | increased renin production from kidneys 
 kidneys are singly innervated by the arterioles that lead to them
 |  | 
        |  | 
        
        | Term 
 
        | action of B2 receptor agonists |  | Definition 
 
        | 1. relaxation of vascular SM; vasodilation results in decreased peripheral vascular resistance and BP 2. reflexive tachycardia with B2 agonist infusion
 3. bronchodilation
 4. uterine SM relaxation
 5. gluconeogenesis and glycogenolysis in the liver
 |  | 
        |  | 
        
        | Term 
 
        | effects of B2 receptor agonist on vasculature |  | Definition 
 
        | relaxation of vascular SM - vasodilation results in decreased peripheral vascular resistance and BP
 |  | 
        |  | 
        
        | Term 
 
        | effects of B2 receptor agonist on heart |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effects of B2 receptor agonist on lungs |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effects of B2 receptor agonist on uterus |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effects of B2 receptor agonist on liver |  | Definition 
 
        | gluconeogenesis and glycogenolysis |  | 
        |  | 
        
        | Term 
 
        | most B1 receptors are located on |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | preload contractility
 afterload
 |  | 
        |  | 
        
        | Term 
 
        | effects of infusing B1 agonist? |  | Definition 
 
        | increase HR increase contractility (force of contraction)
 
 afterload - NOT increased with selective B1 agonist
 
 preload - not increased directly by B1; determined by veins
 |  | 
        |  | 
        
        | Term 
 
        | effect on afterload with selective B1 agonist? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | why does preload increase with B1 receptor agonists? |  | Definition 
 
        | not directly determined by veins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | airway skeletal muscle BV
 BV going to liver
 
 NOT in central BV
 |  | 
        |  | 
        
        | Term 
 
        | which BV do not contain B2 receptors? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effect on HR with infusion of a1 receptor agonist? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effect on HR with infusion of B2 receptor agonist? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NE is an agonist to which receptors? |  | Definition 
 
        | a1, a2, B2 adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | effect of NE in renal BV? |  | Definition 
 
        | induces profound constriction of renal BV dangerously reduces renal blood flow
 
 problem in patient with low GFR
 |  | 
        |  | 
        
        | Term 
 
        | is NE effective in oral admin? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | why is NE not effective when administered orally? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | epi is an agonist to which receptors? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what receptor mediates bronchodilator effect of epi? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what complicates the B2 bronchodilator effect of epi? |  | Definition 
 
        | cardiac stimulation - B1 and
 elevations in systolic BP - a1
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | emergency management of anaphylactic shock - characterized by severe bronchial constriction and CV collapse included as a vasoconstrictor agent in most local anesthetic (procaine-like) preparations
 |  | 
        |  | 
        
        | Term 
 
        | why is epi included in most local anesthetic preparations? |  | Definition 
 
        | as a vasoconstrictor agent to limit diffusion of local anesthetic
 |  | 
        |  | 
        
        | Term 
 
        | side effects of epi used parenterally in high doses? |  | Definition 
 
        | can produce cardiac arrhythmia |  | 
        |  | 
        
        | Term 
 
        | when can epi produce cardiac arrythmias? |  | Definition 
 
        | when used parenterally in high doses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | by parenteral injection - as cardiac stimulant in emergencies inhalation or injection - as bronchodilator
 |  | 
        |  | 
        
        | Term 
 
        | which receptor does NE not target physiologically? |  | Definition 
 
        | B2 epi does - accounts for difference in CV response between the two
 |  | 
        |  | 
        
        | Term 
 
        | which binds a2 with higher affinity: epi or NE? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the physiologically more important location of a2 receptors? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the physiologically most important ligand for a2 receptors? why? |  | Definition 
 
        | NE epi is not released at the neuroeffector junction which is the physiologically most important location of a2 receptors
 epi can bind a2 - not its primary role
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prototype a1 selective agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | applied topically to the nasal mucosa - induces vasoconstriction to improve air flow works well for stuffy noses and common cold
 |  | 
        |  | 
        
        | Term 
 
        | phenylephrine systemic use |  | Definition 
 
        | increase BP - induces a vagally-mediated reflex of slowing the heart in patients with paroxysmal tachycardia |  | 
        |  | 
        
        | Term 
 
        | clonidine and a-methyl-dopa type |  | Definition 
 
        | agonist at presynaptic a2 adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | a-methyl-dopa is converted to ____ and stored in ____ |  | Definition 
 
        | a-methylnorepinephrine sympathetic nerve terminals
 |  | 
        |  | 
        
        | Term 
 
        | what is the classic non-selective B adrenergic agonist? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | agonist of B1 and B2 adrenergic receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | by inhalation as a bronchial dilator |  | 
        |  | 
        
        | Term 
 
        | isoproterenol side effects |  | Definition 
 
        | induces tachycardia more frequently than B2 selective agonists (lacks specificity) |  | 
        |  | 
        
        | Term 
 
        | dobutamine tends to have ____ action on the _____ than dopamine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | agonist for B-adrenergic receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used to stimulate the heart in cardiogenic shock |  | 
        |  | 
        
        | Term 
 
        | metaproterenol, albuterol, terbutaline, and salmeterol type |  | Definition 
 
        | selective agonist for B2 adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | metaproterenol, albuterol, terbutaline, and salmeterol use |  | Definition 
 
        | used for bronchodilation in management of reversible airway diseases (asthma, COPD) |  | 
        |  | 
        
        | Term 
 
        | metaproterenol, albuterol, terbutaline, and salmeterol delivery |  | Definition 
 
        | by inhalers - deliver meds to airway and avoid confounding effects |  | 
        |  | 
        
        | Term 
 
        | who typically gets metaproterenol, albuterol, terbutaline, and salmeterol toxicity |  | Definition 
 
        | patients with dyspnea and anxiety about not being able to breath - often take too much of the drugs |  | 
        |  | 
        
        | Term 
 
        | effects of taking too much metaproterenol, albuterol, terbutaline, and salmeterol |  | Definition 
 
        | drives Na/K ATPase - can cause hypokalemia and problems that go along with it |  | 
        |  | 
        
        | Term 
 
        | effects of dompamine at moderate doses? |  | Definition 
 
        | agonist of D1 dopaminergic receptors relaxes SM in renal BV and improves renal blood flow
 |  | 
        |  | 
        
        | Term 
 
        | effects of dopamine at high doses |  | Definition 
 
        | agonist of cardiac B1 (and B2) receptors increases cardiac contractility
 |  | 
        |  | 
        
        | Term 
 
        | effects of dopamine at VERY high doses |  | Definition 
 
        | becomes an agonist of a1 adrenergic receptors produce vasoconstriction and raise BP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | short - rapid inactivation by hepatic MAO and COMT |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rapid by hepatic MAO and COMT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | found in many plants used in China for >200 years
 introduced in West medicine in 1924 as the first orally active sympathomimetic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-catechol phenylisopropylamine |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct a1 and B2 adrenergic activity |  | 
        |  | 
        
        | Term 
 
        | ephedrine indirect action |  | Definition 
 
        | mainly - indirectly to promote release of endogenous NE |  | 
        |  | 
        
        | Term 
 
        | how does ephedrine mostly act? |  | Definition 
 
        | indirectly promote release of endogenous NE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | principal use - decongestant also recommended for stress incontinence in women
 |  | 
        |  | 
        
        | Term 
 
        | what drug would cause slight decrease in HR, increase in systolic, diastolic, and mean BP, and a large increase in peripheral resistance? |  | Definition 
 
        | NE - get reflexive bradycardia from peripheral vasoconstriction despite B1 activation (from baroreceptor reflex) could be phenylephrine - same BP response (maybe larger); HR reduced more because no B1 action |  | 
        |  | 
        
        | Term 
 
        | what drug would cause slight increase in HR, increase in systolic BP, decrease in diastolic BP, very minimal increase in mean BP, and a slight decrease in peripheral resistance? |  | Definition 
 
        | epi - acts on B2 eliminates rise in BP seen with NE
 don't get reflexive bradycardia seen with NE
 binds B1 - increases HR
 B2 actions on BV - primarily in liver and skeletal muscle
 |  | 
        |  | 
        
        | Term 
 
        | what drug would cause significant increase in HR, slight increase in systolic BP, decrease in diastolic BP, slight decrease in mean BP, and a large decrease in peripheral resistance? |  | Definition 
 
        | isoproterenol - B1 and B2 only; no a big increase in HR
 no vascoconstrictor response
 enormous change in peripheral resistance
 |  | 
        |  | 
        
        | Term 
 
        | peripheral resistance is the relationship between? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | pressure from inflow (aortic flow) - resistance to pressure (outflow) = |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is tocolytic therapy? |  | Definition 
 
        | use of B adrenergic agents to attenuate premature labor, delay delivery, allow fetal maturation thereby - reducing neonatal morbidity and mortality
 |  | 
        |  | 
        
        | Term 
 
        | what is a common side effect of B-adrenergic tocolytic therapy for treatment of preterm labor? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what drug is often used for tocolytic therapy? |  | Definition 
 
        | terbutaline (B-adrenergic agonist) |  | 
        |  | 
        
        | Term 
 
        | how do B-adrenergic agonists control serum K? |  | Definition 
 
        | activate Na/K ATPase by increasing cAMP - take K out of blood and store in cell --> hypokalemia |  | 
        |  | 
        
        | Term 
 
        | what can happen with abrupt withdrawal of a B adrenergic agonist? |  | Definition 
 
        | can get rebound hyperkalemia |  | 
        |  | 
        
        | Term 
 
        | what are the major side effects of B agonists? |  | Definition 
 
        | cardiac arrhythmias hypokalemia
 can precipitate angina
 insomnia
 anxiety
 tremor
 |  | 
        |  | 
        
        | Term 
 
        | what are the major side effects of a agonists? |  | Definition 
 
        | headache **reflexive bradycardia
 excitability
 restlessness
 can precipitate angina
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct and indirect agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting sympathomimetics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | normal byproduct of tyrosine metabolism |  | 
        |  | 
        
        | Term 
 
        | where is tyramine found in high concentrations? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | enters NE nerve terminal via the amine transporter and causes NE release |  | 
        |  | 
        
        | Term 
 
        | tyramine in converted to ____ by ______ |  | Definition 
 
        | octopamine dopamine-B-hydroxylase
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | readily metabolized by MAO |  | 
        |  | 
        
        | Term 
 
        | in what patients are the effects of tyramine intensified? |  | Definition 
 
        | patients treated with MAO inhibitors |  | 
        |  | 
        
        | Term 
 
        | how does drug tolerance to tyramine develop? |  | Definition 
 
        | develops as NE is completely replaced by octopamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting sympathomimetic |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | do amphetamines have direct effect on adrenergic receptors? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | effect of amphetamines on CNS? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting sympathomimetic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks neuronal uptake1 pathway for NE extends half life of NE at synaptic cleft
 |  | 
        |  | 
        
        | Term 
 
        | what is important to know about cocaine toxicity? |  | Definition 
 
        | negative impact can be played out over 72-98 hours after ingested toxicity is potentially several days after use because of long half life
 |  | 
        |  |